NSC |
Compound |
Enrichment |
Correlation |
NSC 731806 |
Null |
0.00109467026514912 |
0.30234106 |
NSC 652809 |
Null |
0.00119931827492062 |
0.72798957 |
NSC 674225 |
2,7-Bis(methoxycarbonylmethyl)-10-methylphenothiazine |
0.00119931827492062 |
0.57757443 |
NSC 684836 |
Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- |
0.00119931827492062 |
0.32884407 |
NSC 698959 |
Null |
0.00119931827492062 |
0.27296973 |
NSC 724631 |
4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione |
0.00119931827492062 |
0.41479165 |
NSC 756166 |
GSK312948A |
0.00119931827492062 |
0.56836404 |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.00119931827492062 |
0.59889965 |
NSC 169774 |
Bromocriptine methanesulfonate |
0.00119931827492064 |
0.31917403 |
NSC 623527 |
Pyrrolidinium, N-(5-carboxypentyl)-N- [2-[2-[3-(octadecyloxy)-2-[(pyrimidine-2yl)oxy]propyloxy] ethoxy]ethyl]-, inner salt |
0.00119931827492064 |
0.14438742 |